Israel Englander’s Labcorp LH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.36M | Buy |
+12,000
| New | +$3.15M | ﹤0.01% | 3360 |
|
|
2025
Q3 | – | Sell |
-17,600
| Closed | -$4.62M | – | 6275 |
|
|
2025
Q2 | $4.62M | Buy |
17,600
+12,100
| +220% | +$2.95M | ﹤0.01% | 3078 |
|
|
2025
Q1 | $1.28M | Buy |
+5,500
| New | +$1.33M | ﹤0.01% | 4162 |
|
|
2024
Q4 | – | Sell |
-70,500
| Closed | -$15.8M | – | 6227 |
|
|
2024
Q3 | $15.8M | Buy |
+70,500
| New | +$15.5M | 0.01% | 1773 |
|
|
2024
Q2 | – | Sell |
-11,200
| Closed | -$2.45M | – | 6262 |
|
|
2024
Q1 | $2.45M | Buy |
11,200
+6,200
| +124% | +$1.37M | ﹤0.01% | 3550 |
|
|
2023
Q4 | $1.14M | Buy |
+5,000
| New | +$1.05M | ﹤0.01% | 4057 |
|
|
2023
Q2 | – | Sell |
-9,661
| Closed | -$1.9M | – | 6440 |
|
|
2023
Q1 | $1.9M | Buy |
+9,661
| New | +$1.99M | ﹤0.01% | 3500 |
|
|
2022
Q1 | – | Sell |
-9,312
| Closed | -$2.51M | – | 7221 |
|
|
2021
Q4 | $2.51M | Buy |
+9,312
| New | +$2.31M | ﹤0.01% | 3555 |
|
|
2021
Q3 | – | Sell |
-23,280
| Closed | -$5.52M | – | 7049 |
|
|
2021
Q2 | $5.52M | Sell |
23,280
-11,640
| -33% | -$2.65M | ﹤0.01% | 2628 |
|
|
2021
Q1 | $7.65M | Buy |
34,920
+10,709
| +44% | +$2.15M | 0.01% | 2085 |
|
|
2020
Q4 | $4.23M | Buy |
24,211
+18,391
| +316% | +$3.18M | ﹤0.01% | 2599 |
|
|
2020
Q3 | $941 | Sell |
5,820
-17,460
| -75% | -$2.77M | ﹤0.01% | 3185 |
|
|
2020
Q2 | $3.32M | Buy |
+23,280
| New | +$3.22M | ﹤0.01% | 2130 |
|
|
2020
Q1 | – | Sell |
-87,300
| Closed | -$12.7M | – | 4207 |
|
|
2019
Q4 | $12.7M | Buy |
87,300
+75,660
| +650% | +$10.9M | 0.02% | 1184 |
|
|
2019
Q3 | $1.68M | Buy |
11,640
+5,820
| +100% | +$849K | ﹤0.01% | 2551 |
|
|
2019
Q2 | $865K | Sell |
5,820
-104,760
| -95% | -$14.6M | ﹤0.01% | 2885 |
|
|
2019
Q1 | $14.5M | Buy |
+110,580
| New | +$13.6M | 0.02% | 1005 |
|
|
2018
Q4 | – | Sell |
-75,660
| Closed | -$11.3M | – | 3977 |
|
|
2018
Q3 | $11.3M | Buy |
+75,660
| New | +$11.5M | 0.01% | 1225 |
|
|
2018
Q1 | – | Sell |
-5,820
| Closed | -$798K | – | 3889 |
|
|
2017
Q4 | $798K | Sell |
5,820
-5,820
| -50% | -$769K | ﹤0.01% | 2834 |
|
|
2017
Q3 | $1.51M | Buy |
+11,640
| New | +$1.55M | ﹤0.01% | 2308 |
|
|
2015
Q1 | – | Sell |
-2,212
| Closed | -$205K | – | 3875 |
|
|
2014
Q4 | $205K | Buy |
+2,212
| New | +$195K | ﹤0.01% | 3621 |
|
|
2014
Q1 | – | Sell |
-38,761
| Closed | -$3.04M | – | 3699 |
|
|
2013
Q4 | $3.04M | Buy |
+38,761
| New | +$3.31M | 0.01% | 1520 |
|
Other funds holding LH
Israel Englander's LH Position: Q2 2026 in Review
Israel Englander increased its Labcorp (LH) stake by 83% in Q2 2026, buying an estimated $27.2M and bringing the position to 228,043 shares worth $63.9M. The position accounts for 0.02% of the portfolio, ranked #745.
Israel Englander first reported a position in LH in Q3 2013 and has held it in 52 quarters since. The position peaked at $280M in Q4 2021. 1,051 funds tracked by Wall St. Rank hold LH as of Q2 2026.
- Israel Englander held 228,043 shares of Labcorp worth $63.9M as of Q2 2026.
- Israel Englander bought 103,470 Labcorp shares in Q2 2026, an estimated $27.2M.
- Labcorp made up 0.02% of Israel Englander's portfolio in Q2 2026, its #745 holding.
- Israel Englander first reported a position in Labcorp in Q3 2013 and has held it in 52 quarters since.
- Israel Englander's Labcorp position peaked at $280M in Q4 2021.
- 1,051 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.
Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.